Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 7Vulvar Neoplasms 1Vaginal Neoplasms 1Vaginal Atrophy 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Metastatic Breastcancer 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Depression 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1Atrophic Vaginitis 1Anxiety Disorders 1

Interventions

Surveys and Questionnaires 1Estradiol 1Dehydroepiandrosterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Atrophic Vaginitis × Dehydroepiandrosterone × Breast × Clear all
NCT03740945 2020-07-31

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

EndoCeutics Inc.

Phase 3 Withdrawn
Breast

Breast Neoplasms, Atrophic Vaginitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡